ScienceDaily: Top Health News |
World Trade Center responders at higher risk for blood cancer-associated mutations, study finds Posted: 07 Mar 2022 10:20 AM PST |
New maps show airplane contrails over the U.S. dropped steeply in 2020 Posted: 07 Mar 2022 10:19 AM PST |
Traffic accidents significantly dropped during COVID-19 lockdown, study finds Posted: 07 Mar 2022 10:19 AM PST |
Harnessing AI and Robotics to treat spinal cord injuries Posted: 07 Mar 2022 08:30 AM PST By employing artificial intelligence (AI) and robotics to formulate therapeutic proteins, a team has successfully stabilized an enzyme able to degrade scar tissue resulting from spinal cord injuries and promote tissue regeneration. The study details the team's ground-breaking stabilization of the enzyme Chondroitinase ABC, (ChABC) offering new hope for patients coping with spinal cord injuries. |
Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows Posted: 07 Mar 2022 08:30 AM PST A new study -- in mice -- suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes the tumors sensitive to chemotherapy and a type of immunotherapy that prompts the immune system's T cells to attack the cancer cells. The therapy more than doubled survival in a mouse model of pancreatic cancer. |
Nanoparticle reduces skin and lung scarring for scleroderma, mouse study finds Posted: 07 Mar 2022 08:30 AM PST Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with biodegradable PLG nanoparticles, which are used in medical sutures, researchers found that the nanoparticles specifically targeted these inflammatory cells and prevented skin and lung fibrosis. Researchers say it's a promising step towards targeted treatment for patients with early scleroderma. |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |